氨基酸作为的化联体:通过生物相容分子促进在水环境中的增强稳定性
Andrea Cucchiaro1, Amelie Scherfler1, Davide Corinti2
1Institute of Pharmacy, Pharmaceutical Chemistry, Center for Molecular Biosciences Innsbruck, University of Innsbruck, Innrain 80-82, A-6020 Innsbruck, Austria.
Journal of medicinal chemistry
|November 8, 2023
概括
研究人员使用乙酸和氨酸开发了一种新的 (II) 复合物. 与以前的版本相比,这种优化的癌症药物显示出更好的稳定性和有效性.
科学领域:
- 药用化学 医学化学
- 无机化学 无机化学
- 癌症治疗方法 癌症治疗方法
背景情况:
- 基于白金的药物是癌症治疗的重要药物,但会引起显著的副作用.
- 开发更有针对性,更少有毒的化疗剂是优先事项.
- 泽伊斯的盐衍生物为基于的新型抗癌药物提供了潜力.
研究的目的:
- 合成和表征一种具有增强稳定性和细胞毒性的新 (II) 复合物.
- 研究氨基酸连接体在调节 (II) 复合物的特性中的作用.
- 优化基于Zeise盐的 (II) 复合物,以改善癌症治疗.
主要方法:
- 新型 (II) 复合物的合成,包括乙酸和各种氨基酸.
- 泽伊斯型前体的结构特征和最终的复合物 (II) 复合物.
- 对抗癌细胞系的复杂稳定性和体外细胞毒性的评估.
主要成果:
- 成功合成了一种新的 (II) 复合物 (4),其中包括乙酸和氨酸连接体.
- 复合物 (4) 与先前开发的模拟物 (5) 相比,表现出增强的稳定性.
- 优化的复合物 (4) 呈现出优异的细胞毒性,其表现优于之前的复合物 (5) 和前体 (1).
结论:
- 加入氨酸作为配体显著改善了复合物的稳定性和细胞毒性概况.
- 这种优化的 (II) 复合体代表了针对性癌症治疗开发的有前途的进步.
- 对氨基酸结合复合物的进一步研究可能会导致更有效,更安全的化疗选择.
相关概念视频
Complexation Equilibria: The Chelate Effect
524
In complexation reactions, metal atoms or cations interact with ligands to form donor-acceptor adducts called metal complexes. Ligands that bind through one donor site are monodentate, ligands with two donor sites are bidentate, and those with more than two donor sites are polydentate ligands. For example, ethylene diamine is a bidentate ligand that binds through two nitrogen donor atoms, forming a five-membered ring. EDTA is a polydentate ligand that binds through four oxygen and two nitrogen...
524
Complexation Equilibria: Factors Influencing Stability of Complexes
380
In complexation reactions, metal cations are the electron pair acceptors, and the ligands are the electron pair donors. The stability of the metal complexes depends primarily on the complexing ability of the central metal ion and the nature of the ligands. Generally, the complexing ability of the metal ion depends on the size and charge of the ion. As the metal ion size increases, the stability of the metal complexes decreases, provided that the valency of the metal ion and the ligands remain...
380
Metal-Ligand Bonds
20.8K
The hemoglobin in the blood, the chlorophyll in green plants, vitamin B-12, and the catalyst used in the manufacture of polyethylene all contain coordination compounds. Ions of the metals, especially the transition metals, are likely to form complexes.
In these complexes, transition metals form coordinate covalent bonds, a kind of Lewis acid-base interaction in which both of the electrons in the bond are contributed by a donor (Lewis base) to an electron acceptor (Lewis acid). The Lewis acid in...
In these complexes, transition metals form coordinate covalent bonds, a kind of Lewis acid-base interaction in which both of the electrons in the bond are contributed by a donor (Lewis base) to an electron acceptor (Lewis acid). The Lewis acid in...
20.8K
EDTA: Chemistry and Properties
1.9K
Polydentate ligands are most widely used in complexometric titrations because they form more stable complexes with the metal ions than mono- or bidentate ligands due to the chelate effect. Examples of polydentate ligands are ethylenediaminetetraacetic acid (EDTA), crown ethers, and cryptands. The most important feature of optimal polydentate ligands is the ability to form 1:1 complexes in a single-step process. Amino carboxylic acid derivatives are frequently used as complexing agents. EDTA is...
1.9K
Complexometric Titration: Ligands
964
Different monodentate and polydentate ligands are used as complexing agents in complexometric titration reactions. The formation of complexes by mono- and bidentate ligands involves two or more intermediate steps, limiting their use as complexing agents. In comparison, polydentate ligands can form complexes with metal ions in a single-step process, facilitating sharper end points. This means polydentate ligands, such as amino carboxylic acid derivatives, are most commonly employed in...
964
Extraction: Advanced Methods
456
Metal ions can be separated from one another by complexation with organic ligands–the chelating agent– to form uncharged chelates. Here, the chelating agent must contain hydrophobic groups and behave as a weak acid, losing a proton to bind with the metal. Since most organic ligands used in this process are insoluble or undergo oxidation in the aqueous phase, the chelating agent is initially added to the organic phase and extracted into the aqueous phase. The metal-ligand complex is...
456


